ArticleJournal of the National Cancer Institute2013

HER2-directed T-cell receptor-mimicking antibody: a "Me Too" or an example of novel antitumor aggressive mimicry?

Giampaolo Bianchini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.